Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
Check Compliance Policies Against Current Operations
From - G2 Compliance Advisor
While labs may draft a comprehensive compliance plan and policies and procedures, those policies, procedures and plan can be a liability if…
Mass Spec Receiving Broader Application
From - Diagnostic Testing & Emerging Technologies
Mass spectrometry (MS) is rapidly transitioning from specialized clinical testing—drugs of abuse confirmations, newborn screening, and steroid analysis—to being broadly applied throughout…
Remember Compliance Risks When Hiring and Firing
From - G2 Compliance Advisor
Hiring and firing staff are difficult challenges. While there are many factors to consider in making either decision, compliance should be front of mind in…
Study Identifies Urine as Preferred Zika Sample
From - Diagnostic Testing & Emerging Technologies
Diagnosing Zika virus is challenging. While diagnosis previously relied on serology, it is difficult to differentiate Zika antibodies from other closely related viruses…
Thermo Fisher Scientific Collaborates with Chinese Hospital on Precision Medicine Platform
From - Laboratory Industry Report
In another sign of the continuing globalization of laboratory services and the allure of the world's most populous nation, Massachusetts-based Thermo Fisher Scientific has…
OIG Report Indicates Limited Success for Senior Medicare Patrol
From - National Intelligence Report
An Office of Inspector General report detailing results of 2015 enforcement efforts by the Senior Medicare Patrol (SMP) show success but not overwhelming recoveries. However, the report cautions that…